2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow proteomic profiling: new trials by email Literature Review of proteomic profiling trials Research Report on proteomic profiling
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer docetaxel, erlotinib hydrochloride, pemetrexed disodium - Lung Cancer | Phase 3 | Unknown | Istituto Scientifico H. San Raffaele | 275 | 2008-02-01 | 2013-08-12 |
| Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer pegfilgrastim, cyclophosphamide, doxorubicin hydrochloride - Breast Cancer | Phase 3 | Unknown | Charing Cross Hospital | 1000 | 2007-01-01 | 2013-08-07 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
Charing Cross Hospital (1) · Istituto Scientifico H. San Raffaele (1)
Italy (1) · United Kingdom (1)
Robert C.F. Leonard, MD, BS, MB (1) · Vanesa Gregor, MD (1)